Percutaneous microwave ablation of benign thyroid nodules

H. Korkusuz; F. Nimsdorf; C. Happel; H. Ackermann; F. Grünwald

doi:10.3413/Nukmed-0678-14-06

Nuklearmedizin - NuclearMedicine, Inhaltsverzeichnis

Nuklearmedizin 2015; 54(01): 13-19
DOI: 10.3413/Nukmed-0678-14-06

Original article

Schattauer GmbH

Percutaneous microwave ablation of benign thyroid nodules

Functional imaging in comparison to nodular volume reduction at a 3-month follow-upPerkutane Mikrowellenablation benigner SchilddrüsenknotenFunktionelle Bildgebung im Vergleich zur noduläre n Volumenreduktion nach drei Monaten

H. Korkusuz

¹Department of Nuclear Medicine, University Hospital Frankfurt am Main

,

F. Nimsdorf

¹Department of Nuclear Medicine, University Hospital Frankfurt am Main

,

C. Happel

¹Department of Nuclear Medicine, University Hospital Frankfurt am Main

,

H. Ackermann

²Department of Biostatistics and Mathematic Modelling, University Hospital Frankfurt am Main, Germany

,

F. Grünwald

¹Department of Nuclear Medicine, University Hospital Frankfurt am Main

› Institutsangaben

Abstract

Summary

Aim: Thyroid nodules represent a common clinical issue. Amongst other minimally invasive procedures, percutaneous microwave ablation (MWA) poses a promising new approach. The goal of this retrospective study is to find out if there is a correlation between volume reduction after 3 months and ^99mTcuptake reduction of treated thyroid nodules. Patients, methods: 14 patients with 18 nodules were treated with MWA. Pre-ablative assessment included sonographical and functional imaging of the thyroid with ^99mTcpertechnetate and ^99mTc-MIBI. Additionally, patients underwent thyroid scintigraphy 24 hours after ablation in order to evaluate the impact of the treatment on a functional level and to ensure sufficient ablation of the targeted area. At a 3-month follow-up, ultrasound examination was performed to assess nodular volume reduction. Results: Mean relative nodular volume reduction after three months was 55.4 ± 17.9% (p < 0.05). ^99mTcuptake 24 hours after treatment was 45.2 ± 31.9% (^99mTc-MIBI) and 35.7 ± 20.3% (^99mTcpertechnetate) lower than prior to ablation (p < 0.05). Correlating reduction of volume and ^99mTc-uptake, Pearson's r was 0.41 (p < 0.05) for nodules imaged with ^99mTc-MIBI and –0.98 (p < 0.05) for ^99mTc-pertechnetate. According to scintigraphy 99.6 ± 22.6% of the determined target area could be successfully ablated. Conclusions: MWA can be considered as an efficient, low-risk and convenient new approach to the treatment of benign thyroid nodules. Furthermore, scintigraphy seems to serve as a potential prognostic tool for the later morphological outcome, allowing rapid evaluation of the targeted area in post-ablative examination.

Zusammenfassung

Schilddrüsenknoten sind ein häufiges klinisches Problem. Wie andere minimal-invasive Techniken stellt die perkutane Mikrowellenablation (MWA) einen viel versprechenden neuen Therapieansatz dar. Das Ziel dieser retrospektiven Studie ist es herauszufinden, ob ein Zusammenhang zwischen Volumenabnahme nach drei Monaten und ^99mTc-Uptake- Abnahme des therapierten Schilddrüsenknotens besteht. Patienten, Methoden: 14 Patienten mit 18 Knoten wurden mit MWA behandelt. Das prä-ablative Prozedere umfasste Ultraschalluntersuchung, funktionelle Bildgebung mit ^99mTc-Pertechnetat und ^99mTc- MIBI. Nach 24 Stunden wurde erneut ein Szintigramm angefertigt, um das Ergebnis der Behandlung auf funktioneller Ebene zu beurteilen. Nach drei Monaten erfolgte die Verlaufskontrolle, bei der sonographisch die Reduktion des Knotenvolumens erfasst wurde. Ergebnisse: Die relative Reduktion des Knotenvolumens betrug nach drei Monaten 55,4 ± 17,9% (p < 0,05). Der ^99mTc-Uptake war 24 Stunden nach der Behandlung um 45,2 ± 31,9% (^99mTc-MIBI) bzw. 35,7 ± 20,3% (^99mTc-Pertechnetat) verringert (p < 0,05). Die statistische Korrelation von Volumenreduktion und ^99mTc-Uptake ergab r-Werte von 0,41 (^99mTc-MIBI) bzw. –0,98 (^99mTcpertechnetate) (p < 0,05). Zudem konnten gemäß Szintigraphie 99,6 ± 22,6% des definierten Zielareals abladiert werden. Schlussfolgerung: Die MWA kann als effizienter und risikoarmer neuer Therapieansatz zur Behandlung benigner Schilddrüsenknoten angesehen werden. Weiterhin scheint es möglich, die Szintigraphie als prognostisches Hilfsmittel und auch zur raschen post-ablativen Beurteilung des Zielvolumens heranzuziehen.

Keywords

Microwave ablation - functional imaging - thyroid nodules - scintigraphy - ^99mTc-pertechnetate - ^99mTc-MIBI

Schlüsselwörter

Mikrowellenablation - funktionelle Bildgebung - Schilddrüsenknoten - Szintigraphie - ^99mTc-Pertechnetat - ^99mTc-MIBI

Volltext

Referenzen

References
1 Ahmed M, Brace CL, Lee FT, Goldberg SN. Principles of and advances in percutaneous Aablation. Radiology 2011; 258: 351-369.
2 Arbab AS, Koizumi K, Toyama K. et al. Technetium-^99m-tetrofosmin, technetium-^99m-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med 1998; 39: 266-271.
3 Banik S, Bandyopadhyay S, Ganguly S. Bioeffects of microwave - a brief review. Bioresour Technol 2003; 87: 155-159.
4 Bennedbaek FN, Hegedüs L. Percutaneous ethanol injection therapy in benign solitary solid cold thyroid nodules: a randomized trial comparing one injection with three injections. Thyroid 1999; 9: 225-233.
5 Cancer Research UK. Thyroid cancer incidence statistics - In Europe and worldwide. www.cancerresearchuk.org/cancer-info/cancerstats/types/thyroid/incidence/#geog. visited 15/05/2014
6 DÖbert N, Balzer K, Diener J. et al. Thyroid sonomorphology, thyroid peroxidase antibodies and thyroid function. New epidemilogical data in unselected German employees. Nuklearmedizin 2008; 47: 194-199.
7 Døssing H, Bennedbæk FN, Hegedüs L. Interstitial laser photocoagulation (ILP) of benign cystic thyroid nodules-a prospective randomized trial. J Clin Endocrinol Metab 2013; 98: 1213-1217.
8 Feng B, Liang P, Cheng Z. et al. Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: experimental and clinical studies. Eur J Endocrinol 2012; 166: 1031-1037.
9 Gallowitsch HJ, Mikosch P, Kresnik E. et al. Thyroid volume and iodine supply of 6 to 17 year old students. Results 3 years after the introduction of increased iodized salt. Nuklearmedizin 1994; 33: 235-238.
10 Gambelunghe G, Fatone C, Ranchelli A. et al. A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules. J Endocrinol Invest 2006; 29: 23-26.
11 Gharib H, Hegedüs L, Pacella CM. et al. Nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J Clin Endocrinol Metab 2013; 98: 3949-3957.
12 Giovanella L, Suriano S, Maffioli M. et al. ^99mTc-sestamibi scanning in thyroid nodules with nondiagnostic cytology. Head Neck 2010; 32: 607-611.
13 Gotthardt M, Stübinger M, Pansegrau J. et al. Decrease of ^99mTc-uptake in autonomous thyroid tissue in Germany since the 1970s. Clinical implications for radioiodine therapy. Nuklearmedizin 2006; 45: 122-125.
14 Guth S, Theune U, Aberle J. et al. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest 2009; 39: 699-706.
15 Ha EJ, Baek JH, Lee JH. The efficacy and complications of radiofrequency ablation of thyroid nodules. Curr Opin Endocrinol Diabetes Obes 2011; 18: 310-314.
16 Ha EJ, Baek JH, Lee JH, Kim JK, Shong YK. Clinical Significance of vagus nerve variation in radiofrequency ablation of thyroid nodules. Eur Radiol 2011; 21: 2151-2157.
17 Hampel R, BennÖhr G, Gordalla A, Below H. Urinary iodide excretion in adults in Germany 2005 meets WHO target. Exp Clin Endocrinol Diabetes 2010; 118: 254-257.
18 Happel C, Truong PN, Bockisch B. et al. Colour-coded duplex-sonography versus scintigraphy. Can scintigraphy be replaced by sonography for diagnosis of functional thyroid autonomy? Nuklearmedizin 2013; 52: 186-191.
19 Huh JY, Baek JH, Choi H. et al. Symptomatic benign thyroid nodules: efficacy of additional radiofrequency ablation treatment session--prospective randomized study. Radiology 2012; 263: 909-916.
20 Jeong WK, Baek JH, Rhim H. et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol 2008; 18: 1244-1250.
21 Kim YJ, Baek JH, Ha EJ. et al. Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors. Eur Radiol 2012; 22: 1573-1578.
22 Kim Y-S, Rhim H, Tae K. et al. Radiofrequency ablation of benign cold thyroid nodules: Initial clinical experience. Thyroid 2006; 16: 361-366.
23 Korkusuz H, Happel C, Grünwald F. Ultrasound guided percutaneous microwave ablation of hypofunctional thyroid nodules: evaluation by scintigraphic ^99mTc-MIBI imaging. Nuklearmedizin 2013; 52: N68.
24 Korkusuz H, Happel C, Heck K. et al. Percutaneous thermal microwave ablation of thyroid nodules: Preparation, feasibility and efficiency. Nuklearmedizin 2014; 53: 123-130.
25 Leidig-Bruckner G, Cichorowski G, Sattler P. et al. Evaluation of thyroid nodules-combined use of ^99mTc-methylisobutylnitrile scintigraphy and aspiration cytology to assess risk of malignancy and stratify patients for surgical or nonsurgical therapy-a restrospective cohort study. Clin Endocrinol 2012; 76: 749-758.
26 Na DG, Lee JH, Jung SL. et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: Consensus statement and recommendations. Korean J Radiol 2012; 13: 117-125.
27 Papini E, Guglielmi R, Bizzarri G. et al. Treatment of benign cold thyroid nodules: a randomized clinical trial of percutaneous laser ablation versus levothyroxine therapy or follow-up. Thyroid 2007; 17: 229-235.
28 Piga M, Cocco MC, Serra A. et al. The usefulness of ^99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. Eur J Endocrinol 2008; 159: 423-429.
29 Ratanaprasatporn L, Charpentier KP, Resnick M. et al. Intra-operative microwave ablation of liver malignancies with tumour permittivity feedback control: a prospective ablate and resect study. HPB (Oxford) 2013; 15: 997-1001.
30 Ross DS. Non-palpable thyroid nodules - managing an epidemic. J Clin Endocrinol Metab 2002; 87: 1938-1940.
31 Saggiorato E, Angusti T, Rosas R. et al. ^99mTc-MIBI imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression. J Nucl Med 2009; 50: 1785-1793.
32 Shamis Y, Taube A, Mitik-Dineva N. et al. Specific electromagnetic effects of microwave radiation on Escherichia coli. Appl Environ Microbiol 2011; 77: 3017-3023.
33 Shamis Y, Croft R, Taube A. et al. Review of the specific effects of microwave radiation on bacterial cells. Appl Microbiol Biotechnol 2012; 96: 319-325.
34 Spiezia S, Garberoglio R, Milone F. et al. Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid 2009; 19: 219-225.
35 Sung JY, Baek JH, Kim KS. et al. Single-session treatment of benign cystic thyroid nodules with ethanol versus radiofrequency ablation: a prospective randomized study. Radiology 2013; 269: 293-300.
36 Valcavi R, Frasoldati A. Ultrasound-guided percutaneous ethanol injection therapy in thyroid cystic nodules. Endocr Pract 2004; 10: 269-275.
37 Valcavi R, Riganti F, Bertani A. et al. Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients. Thyroid 2010; 20: 1253-1261.
38 Vanderpump MPJ. The epidemiology of thyroid diseases. Br Med Bull 2011; 99: 39-51.
39 Wood MA, Shaffer KM, Ellenbogen AL, Ownby ED. Microbubbles during radiofrequency catheter ablation: composition and formation. Heart Rhythm 2005; 2: 397-403.
40 Yue W, Wang S, Wang B. et al. Ultrasound guided percutaneous microwave ablation of benign thyroid nodules: Safety and imaging follow-up in 222 patients. Eur J Radiol 2012; 82: 11-16.